These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8383006)
1. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Hsieh LL; Hsieh TT Cancer Res; 1993 Mar; 53(6):1278-80. PubMed ID: 8383006 [TBL] [Abstract][Full Text] [Related]
2. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Hsieh LL; Hsu SW; Chen DS; Santella RM Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043 [TBL] [Abstract][Full Text] [Related]
3. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts. Yu MW; Lien JP; Liaw YF; Chen CJ Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363 [TBL] [Abstract][Full Text] [Related]
4. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Chen CJ; Zhang YJ; Lu SN; Santella RM Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290 [TBL] [Abstract][Full Text] [Related]
5. Aflatoxin B1 transfer and metabolism in human placenta. Partanen HA; El-Nezami HS; Leppänen JM; Myllynen PK; Woodhouse HJ; Vähäkangas KH Toxicol Sci; 2010 Jan; 113(1):216-25. PubMed ID: 19875679 [TBL] [Abstract][Full Text] [Related]
6. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702 [TBL] [Abstract][Full Text] [Related]
7. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis. Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216 [TBL] [Abstract][Full Text] [Related]
9. Oxidative metabolism of aflatoxin B1 by lipoxygenase purified from human term placenta and intrauterine conceptal tissues. Datta K; Kulkarni AP Teratology; 1994 Oct; 50(4):311-7. PubMed ID: 7716738 [TBL] [Abstract][Full Text] [Related]
10. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans. Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618 [TBL] [Abstract][Full Text] [Related]
11. The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver. Barraud L; Douki T; Guerret S; Chevallier M; Jamard C; Trepo C; Wild CP; Cadet J; Cova L Cancer Detect Prev; 2001; 25(2):192-201. PubMed ID: 11341355 [TBL] [Abstract][Full Text] [Related]
12. In vivo aflatoxin B1 metabolism and hepatic DNA adduction in zebrafish (Danio rerio). Troxel CM; Reddy AP; O'Neal PE; Hendricks JD; Bailey GS Toxicol Appl Pharmacol; 1997 Mar; 143(1):213-20. PubMed ID: 9073610 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and nontumorous liver tissue. Santella RM; Zhang YJ; Chen CJ; Hsieh LL; Lee CS; Haghighi B; Yang GY; Wang LW; Feitelson M Environ Health Perspect; 1993 Mar; 99():199-202. PubMed ID: 8391434 [TBL] [Abstract][Full Text] [Related]
15. Low hepatic glutathione S-transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized mice. Shupe T; Sell S Toxicol Lett; 2004 Mar; 148(1-2):1-9. PubMed ID: 15019083 [TBL] [Abstract][Full Text] [Related]
16. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1. Chen SY; Chen CJ; Tsai WY; Ahsan H; Liu TY; Lin JT; Santella RM Nutr Cancer; 2000; 38(2):179-85. PubMed ID: 11525595 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273 [TBL] [Abstract][Full Text] [Related]
18. Immunologic methods for the detection of carcinogen adducts in humans. Santella RM; Yang XY; Hsieh LL; Young TL Prog Clin Biol Res; 1990; 340C():247-57. PubMed ID: 2199982 [TBL] [Abstract][Full Text] [Related]
19. [Synergism of three risk factors in hepatocellular carcinogenicity]. Zhou Y; Peng W; Yao J Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Sep; 30(5):289-91. PubMed ID: 9388889 [TBL] [Abstract][Full Text] [Related]
20. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin. Hayes JD; Judah DJ; Neal GE Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]